Login / Signup

Botulinum toxin as a double-edged sword in alopecia: A systematic review.

Yuanzhuo WangHanlin ZhangQingyue ZhengKeyun TangRou-Yu FangQiuning Sun
Published in: Journal of cosmetic dermatology (2020)
The results showed that botulinum toxin may function as a double-edged sword and have a low degree of efficacy and safety in treating alopecia. The study may be useful to remind the physicians of adverse effects in clinical practice and pave the way for further research. A larger, randomized, placebo-controlled study is warranted.
Keyphrases
  • botulinum toxin
  • double blind
  • clinical practice
  • primary care
  • open label
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii